Rare diseases
Investigational molecules
Locations
Hippokrateslaan 10, Batiment 54, 1200 Woluwe-Saint-Lambert, Belgium
Cliniques Universitaires Saint-Luc in Woluwe-Saint-Lambert, Belgium specialises in clinical trials of conditions such as Breast cancer, Crohn's disease, Ovarian cancer, Non-small cell lung cancer, and other specialisations. This site conducts important research.
The medical center is at the forefront of research in gastroenterology, focusing on innovative treatments for inflammatory bowel diseases. The center's work in this field is pivotal in advancing therapeutic options for conditions such as ulcerative colitis and Crohn's disease.
Through rigorous clinical trials, the center is exploring the efficacy of novel biologics and targeted therapies, aiming to improve patient outcomes and quality of life.
Specializing in oncology, the center is dedicated to developing cutting-edge treatments for various cancers, including solid tumors and hematologic malignancies. The research conducted here is instrumental in enhancing the understanding of cancer biology and treatment.
The center's commitment to personalized medicine is evident in its efforts to tailor therapies based on genetic and molecular profiles, thereby optimizing treatment efficacy and minimizing adverse effects.
In the realm of neurology, the center is pioneering research into neurodegenerative diseases and neurological disorders. Its work is crucial in developing therapies that target the underlying mechanisms of conditions such as Alzheimer's disease and epilepsy.
By leveraging advanced imaging techniques and biomarker analysis, the center aims to enhance early diagnosis and intervention strategies, ultimately improving patient care and outcomes.
The center's research in immunology is focused on understanding and manipulating the immune system to treat autoimmune diseases and enhance vaccine efficacy. This research is vital for developing new therapeutic approaches for conditions like psoriatic arthritis and hemophilia.
Through innovative clinical trials, the center is exploring the potential of gene therapy and biologics to modulate immune responses and achieve long-term disease remission.
In nephrology, the center is advancing research on kidney diseases, particularly focusing on genetic and proteinuric conditions. The center's efforts are crucial in developing targeted therapies for diseases such as APOL1-mediated kidney disease.
By integrating genetic research with clinical applications, the center aims to provide personalized treatment options that address the specific needs of patients with complex renal conditions.
More sites in Woluwe-Saint-LambertBelgium
Clinical trials currently enrolling participants at this site.
BelgiumBelgiumLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
BelgiumA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
BelgiumA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
BelgiumStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
BelgiumStudy of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
BelgiumA study comparing XL092 versus everolimus in patients with previously treated advanced or metastatic neuroendocrine tumors
BelgiumA Study of Darovasertib Before Surgery or Radiation Therapy for Patients with Early-Stage Uveal Melanoma That Has Not Spread
BelgiumA Study of Ivonescimab Combined with Fluorouracil, Folinic Acid, and Oxaliplatin Compared to Bevacizumab for Patients with Metastatic Colorectal Cancer
BelgiumStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
BelgiumLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
BelgiumMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
